Market Research Reports, Business Consulting Services & Analytics

Growing incidences of Basal Cell Carcinoma among the geriatric population are driving the growth of the Basal Cell Carcinoma Market

HYDERABAD, TELANGANA, INDIA, January 31, 2023 /EINPresswire.com/ -- The Basal Cell Carcinoma Market size is forecast to reach $7.37 billion by 2025, growing at a CAGR of 8.56% during the forecast period 2020-2025. Basal cell carcinoma (BCC) is the most common form of skin cancer and the most frequently occurring form of all cancers. In the U.S. alone, more than 4 million cases are diagnosed each year. BCCs arise from abnormal, uncontrolled growth of basal cells. This is owing to the slow growth of BCCs which are mostly curable and cause minimal damage when caught and treated early. Understanding BCC causes, risk factors and warning signs can help detect them early when they are easiest to treat and cure. Growing incidences of Basal cell carcinoma among the geriatric population, changing habits of the urban population living in developed countries and increased awareness about the reoccurrence rate and progressiveness of the disease are driving the market growth in recent years. In addition, major market development of key players like Sanofi and Provectus are other factors driving the growth of the market.

Click here to browse the complete report summary:
https://www.industryarc.com/Report/16907/basal-cell-carcinoma-market.html

Key Takeaways

1. North America dominated the Basal Cell Carcinoma Market in the year 2019 owing to growing cases of BCC in the geriatric population, increased use of immunosuppressants and increasing key developments by market players. The Basal Cell Carcinoma Market scope for different regions will be provided in the final report.

2. Growing incidences of Basal cell carcinoma among the geriatric population, changing habits of the urban population living in developed countries and increased awareness about the reoccurrence rate and progressiveness of the disease have helped in the significant growth of the Basal Cell Carcinoma Market.

3. Detailed analysis of the Strength, Weaknesses and Opportunities of the prominent players operating in the market will be provided in the Basal Cell Carcinoma Market report.

4. Delay in accessing medical conditions, lack of awareness among patients and cost of certain therapeutics is anticipated to hamper the market growth of the Basal Cell Carcinoma Industry.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=16907

Segment Analysis

1. Surgery held the largest share in the treatment type segment of the Basal Cell Carcinoma Market in 2019 and is estimated to grow at a CAGR of 7.89% during the forecast period 2020-2025. Basal cell carcinoma is most often treated with surgery to remove cancer and some of the healthy tissue around it. Options might include Surgical excision. In this procedure, the doctor cuts out the cancerous lesion and a surrounding margin of healthy skin. Cost-efficiency of Basal Cell Carcinoma surgery and R&D activities on better-acting surgeries by key market companies are further aiding in the growth of this segment.

2. Hospitals held the major share in the distribution channel segment of the Basal Cell Carcinoma Market in 2019. For patients diagnosed with basal cell carcinoma, the hospitals provide renowned experts in skin cancer and dermatologic surgery who develop a personalized treatment plan for patients which can include a number of options that have been shown to be very successful in treating BCC. The types include Mohs micrographic surgery, Cryosurgery and electrodesiccation and curettage among others. As a result, people are attracted greatly to the treatment done in hospitals.

3. North America dominated the geography segment of the Basal Cell Carcinoma Market in 2019 with a share of more than 40.2% in 2019, followed by Europe. The presence of developed healthcare infrastructure in countries such as the U.S., Canada, Mexico, and others, technological advancement in healthcare infrastructure, with better and advanced healthcare facilities growing prevalence of basal cell carcinoma, and increasing key developments by market players have helped in the growth of Basal Cell Carcinoma Market infrastructure in this region.

Competitive Landscape:

The top 5 players in the Basal Cell Carcinoma Industry are -

1. Allergan, Inc.
2. Novartis AG
3. Taro Pharmaceutical Industries Ltd.
4. Perrigo Company plc
5. Valeant Pharmaceuticals International, Inc.

Click on the following link to buy the Basal Cell Carcinoma Market Report:
https://www.industryarc.com/reports/request-quote?id=16907

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Venkat Reddy
IndustryARC
+1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.